Search results for: 'engineering research ad development'

This Frost & Sullivan research examines the growing need for artificial intelligence (AI) services to help businesses meet key goals and objectives, as well as the strategic position of public cloud service providers to develop and launch successful AI capabilities for customers. The report discusses the importance of public cloud providers in the ...

11 Nov 2022  |  North America  |  Market Research

Global Contract Research Organization (CRO) Growth Opportunities

Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth

Infographics

×

Key Issues Addressed

The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and e...

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

The automotive industry has been under increasing pressure to improve fuel economy and emissions in the last few years. Emission reduction has become the primary goal with fuel economy being a secondary aspect, in line with the global demand for carbon-neutral mobility. The focus on emission reduction has had a significant impact on the Internal...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

09 Mar 2021  |  North America  |  Market Research

Future Skateboard and Platform Architecture Strategies of Electric Vehicle (EV) Companies

Automakers Should Strategize Best-in-class Flexible and Variable EV/AD Platforms that can Seamlessly Transition into Mobility Intelligence Platforms

Infographics

×

As the automotive industry converges toward Connected, Autonomous, Shared, and Electric (CASE) mobility, OEMs are working on re-engineering their conventional platforms to accommodate electric vehicle (EV) components such as batteries and motors. However, the industrys transition from a vehicle-centric to a service-centric approach necessitates the...

07 Nov 2016  |  North America  |  Market Research

Market Analysis of Premium European OEMs' ADAS and Automated Driving (AD) Strategies

Along with Level 3 and 4 Functions, Shared Mobility Portfolio to Play a Key Role in OEMs’ Future Business Models

Infographics

×

While OEMs are racing towards achieving L4 and 5 automation features in their vehicles in developed markets such as NA and Europe, there will be major improvements in the ADAS sensors that will be used to achieve the desired features. Every OEM is working on a strategy that is different from others in terms of the level of automation desired. With ...

27 Nov 2019  |  North America  |  Market Research

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Infographics

×

Key Issues Addressed

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...